The British Association for Parenteral and Enteral Nutrition CIO 

Financial Statements for the period ended 31 December 2023 

Registered Charity number 1186719 (previously 1023927) 

1 



The British Association for Parenteral and Enteral Nutrition CIO for the period ended 31 December 2023 

|Index||
|---|---|
||Page|
|Report of the Trustees|3|
|Statement of Trustees’ responsibilities|14|
|Report of the Independent Examiner|15|
|Statement of Financial Activities|16|
|Balance sheet|17|
|Accounting policies and notes to the financial statements|18|



2 



The British Association for Parenteral and Enteral Nutrition CIO for the period ended 31 December 2023 

## **Report of the trustees** 

The trustees are pleased to present their report together with the financial statements of The British Association for Parenteral and Enteral Nutrition CIO for the period ended 31 December 2023.  On 20 July 2020 all activities and funds were transferred to a newly registered charity The British Association for Parenteral and Enteral Nutrition CIO (Charity number 1186719) which was registered on 3 December 2019. 

The financial statements comply with the Charities Act 2011, the Council’s Constitution and Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (updated 1 January 2019). 

## **AIMS AND OBJECTIVES** 

BAPEN’s objects as recorded in its Constitution were: 

1. the relief of sickness in those who have become, or are likely to become, malnourished and who are unable to consume or absorb normal food in sufficient quantities to effect recovery; 

2. the advancement of education of health workers of all kinds, patients, policy makers and the general public, in the importance of and the methods for, the prevention and treatment of malnutrition during illness; 

3. the promotion of research into all aspects of clinical nutrition and human metabolism on condition that the results of such research are published. 

## **BAPEN’s key objectives were to:** 

- a. Raise awareness of the problem of malnutrition in the UK 

- b. Support a clinical governance framework to underpin the nutritional management of patients 

- c. Enhance knowledge and skills in clinical nutrition through education and training 

- d. Communicate the clinical and economic benefits of nutritional care to healthcare workers, policy makers and the public 

- e. Promote multi professional research to contribute to the evidence base for malnutrition and its treatment 

- f. Establish standards of clinical practice in nutrition support 

## **Public Benefit** 

The Trustees believe that they have complied with their duty to have due regard to guidance on public benefit published by the Charity Commission in exercising their powers and duties and in planning their objectives and activities during the year. 

3 



The British Association for Parenteral and Enteral Nutrition CIO for the period ended 31 December 2023 

## **ACHIEVEMENTS AND PERFORMANCE (President’s report 2023)** 

2023 marked BAPEN’s first year on its new five-year strategy path. We launched this strategy to define our practice, our ways of operating and the values which define our culture. It provided us with an ambitious impetus for our future direction as an organisation through a changing external health and social care environment. I am proud of the progress we made this year against this strategy, which I will go into more detail below. 

2023 had enabled us to thoroughly reflect on how far we’ve come, through this strategy and our 30[th] anniversary, and laid a great foundation for a progress filled year. Collaboration was a core characteristic of the year, as BAPEN, its Core Groups and Special Interest Groups all worked together and with other partners to deliver for our members, colleagues in health and social care, and most importantly our patients. 

In the last of my President’s Reports, I’m delighted to outline the significant contributions made by so many of you throughout 2023. 

## **BAPEN Annual Strategy Delivery Report** 

As I mentioned, towards the end of 2022 BAPEN unveiled its five-year strategy. The newly launched values of ‘Listen’, ‘Lead’, ‘Share’ and ‘Support’ are the principles that have already begun to guide the way we act on our vision. Furthermore, our three strategic priorities of ‘Knowledge’, ‘Reach’ and ‘Sustainability’ ensure our focus and efforts are responding to the changing clinical environment and the increasing demands placed upon all those working in health and social care. 

Developing a strategy is a task which involves considered thought, planning, and collaboration, but executing it is harder. That’s why we’ve put in place the steps to remain accountable to BAPEN members. Our annual Strategy Delivery Report takes each of our strategic priorities into consideration, reflecting on and analysing activities, resources, and events which have helped BAPEN to achieve the aims we set out in the five-year strategy. 

Within the ‘Knowledge’ pillar, we have developed healthcare professional and patient resources, podcast episodes, and established a new professional group in the Patient Network Group SIG. Under ‘Reach’, BAPEN has made strides to cement its influence with key decision makers, reiterating the importance of good nutritional care. We’ve joined a new social media platform in Instagram, continued our partnerships with key organisations such as the Inequalities in Health Alliance and NHS England Nutrition and Hydration Advisory Board, and the assisted mealtimes working group to name a few. Finally, for ‘Sustainability’, the charity has brought together a new Special Interest Group focussed on developing work streams to improve sustainability within clinical nutrition, and become a member of the UK Health Alliance on Climate Change (UKHACC). This is an alliance of healthcare organisations that coordinate action, provide leadership, and amplify the voice of health professionals across the UK. This provides just a snapshot of the steps we have taken to deliver against our strategic objectives. I know that the BAPEN team and all our members are committed to continued progress, and I look forward to seeing what we’re able to achieve in the next four years of this strategy, and beyond. 

## **BAPEN’s Annual Conference** 

On 28[th] and 29[th] November, over 700 delegates gathered in Scotland’s capital for BAPEN’s Annual Conference. It was a pleasure to experience such a vibrant energy around the event as we enjoyed wide-ranging presentations and fascinating discussions on a subject close to all of our hearts, good nutritional care. 

The standard of speakers and presentations at the Conference was truly inspirational. We welcomed posters on a broad range of nutritional topics, including blended diets for tube-fed children, the effects 

4 



The British Association for Parenteral and Enteral Nutrition CIO for the period ended 31 December 2023 

of a plant-based high energy and protein enteral feed and a 10-year experience of an HPN centre in England focussed on reviewing catheter related blood stream infections. The Pennington Lecture was delivered by the brilliant Anne Holdoway focussed on optimising nutritional care through champions, culture and collaboration. 

Overall, Edinburgh was the perfect backdrop to refocus our energy once again on facilitating improvements in nutritional care. Every one of us working within nutritional care in the UK is seeking to continually improve patient experiences and outcomes, and Conference was a welcome reminder of the vast talent and dedication across the UK. We look forward to seeing you in Gateshead for BAPEN Conference 2024! 

## **BAPEN’s new website** 

A significant project for BAPEN in 2023 was the new website. We wanted to ensure that the new website, which is effectively our organisation’s ‘shop window’, was fit for purpose and provided members with the information they seek, intuitively. 

This project involved a significant engagement phase. We conducted a members’ survey to understand the priorities of the people who visit our website the most. From there, we created a website steering committee which was tasked with ensuring all content on the new website was relevant and up to date. Hopefully, you have found it easier to access key information, whether that’s BAPEN guidelines, ‘MUST’, or details of meetings. 

## **UK Malnutrition Awareness Week 2023** 

BAPEN is proud to have continued our close working relationship with the Malnutrition Task Force (MTF) for the sixth straight year as we delivered UK Malnutrition Awareness Week (UKMAW) 2023. As with previous years, each day of the week had a designated theme, and we were delighted to see the return of the popular _Interactive Tuesday_ and the weekend’s _Nutrition Superheroes_ . In 2023, we invited people to nominate their heroes via the BAPEN and MTF website earlier in the week so that we could collate all the shout-outs and commend them, it’s so important to ensure that we are recognising our invaluable colleagues. 

As part of UKMAW 2023, we also set out to engage with leading supermarkets in the UK to understand the initiatives and programmes in place to support older or vulnerable people who may be more likely to be at risk of malnutrition or dehydration. Following positive outreach and engagement, we also secured commitment to support the campaign on social media from Waitrose, the Co-op and the British Retail Consortium (BRC), a fantastic achievement to help grow more public awareness. 

Building year on year, this annual campaign does an invaluable job to raise awareness and improve understanding of nutritional needs, and I’m sure you’ll agree that we can’t wait to see what is in store for 2024. 

The campaign was well integrated with the Malnutrition Action Group’s (MAG) National Screening Survey, run through the month of November. By screening a large number of people across the UK, we can build a better picture of the scale of malnutrition and the treatment that people are receiving, and also examine trends over the years to inform our future focus so thank you to all those who submitted data. A huge well done to the MAG team for all your efforts. 

## **A final note as the outgoing President** 

After a rewarding (and longer than intended, due to Covid-19) tenure as President of BAPEN, it was a pleasure to hand over the reins to Dr Nick Thompson during this year’s Conference. I am incredibly 

5 



The British Association for Parenteral and Enteral Nutrition CIO for the period ended 31 December 2023 

proud of what we have achieved together whilst I’ve been at the helm of the organisation, not least working to unite and support our speciality through the unprecedented tumultuous pandemic. It has been an honour to work with members, stakeholders, and brilliant, selfless and committed colleagues during my Presidency. Having been involved with BAPEN in some capacity since joining the BANS Committee in 2008, it's been a pleasure to steer the ship and to be involved in some brilliant opportunities to help improve nutritional care in the UK and drive much-needed change. 

I believe this to be a very exciting time for BAPEN as an organisation, with our new strategy coming into effect and the rapidly changing external health environment. Please do join me in continuing to support BAPEN, whether as a member or part of the team behind the organisation. And best of luck (though you won’t need it) to my successor, Nick! 

## **FINANCIAL REVIEW (Treasurer’s report)** 

## **Overview** 

The financial position of BAPEN has changed and improved dramatically over the last decade. Previously surplus was mostly derived from corporate/industry sponsorship and through the annual conference. Whilst BAPEN still attracts corporate/industry membership/sponsorship, this was almost £20,000 less than in 2022 at £74,400. Conference remains positive, producing a surplus, albeit reduced due to higher overheads: larger venues and better-quality audio-visual delivery (see conference section). BAPEN has grown considerably in its work over this decade and weathered the storm of COVID-19.  To further strengthen BAPEN’s delivery of its charitable aims and objectives, updated in the BAPEN Strategy 2022-2027, a new secretariat and conference provider were tendered for and appointed, commencing January 2023. There was a change of accountants also as the previous accountant was reducing his workload; the accounts were then assigned to the accountants of Medivents. This, with the increased charges of staging the annual educational conference, has reflected a significant increase in costs. For the sixth year in a row, a year end surplus was delivered, but this was reduced, £117,446 in 2023 vs. £291,729 in 2022, as BAPEN has increased its spending on charitable activities. A significant income is now derived by the copyright licensing use of the ‘MUST’ by pharmaceutical companies. Whilst this has been the bedrock of BAPEN’s financial growth, the licences are renewed annually which makes deriving a budget for more than 1-2 years in advance more challenging. 

This is an outstanding achievement for a charity whose leadership team and members have been challenged within their healthcare roles recovering waiting list times grown during the pandemic and during industrial action, whilst maintaining a focus on securing not just the stability and sustainability of the charity, but its growth. The current financial position is supporting BAPEN to meet its charitable aims, with projects planned for delivery in 2024: Core Group and Specialist Interest Group funding, and membership led quality improvement project and research awards. Further projects for 2025, such as the Nutrition Support Team course, and tendering for Public Relations Media will make use of the surplus being acquired. 

6 



The British Association for Parenteral and Enteral Nutrition CIO for the period ended 31 December 2023 

## **Figure 1a: Summary of year end surplus/deficit** 


**----- Start of picture text -----**<br>
£350,000<br>£300,000<br>£250,000<br>£200,000<br>£150,000<br>£100,000<br>£50,000<br>£0<br>2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023<br>(£50,000)<br>(£100,000)<br>(£150,000)<br>**----- End of picture text -----**<br>


## **Figure 1b: Summary of changes in income and expenditures** 


**----- Start of picture text -----**<br>
£800,000<br>£700,000<br>£600,000<br>£500,000<br>£400,000<br>£300,000<br>£200,000<br>£100,000<br>£0<br>2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023<br>(£100,000)<br>TOTAL INCOME CORPORATE SUPPORT TOTAL EXPENDITURE YR END PROFIT/LOSS<br>(£200,000)<br>**----- End of picture text -----**<br>


7 



The British Association for Parenteral and Enteral Nutrition CIO for the period ended 31 December 2023 

## **Income** 

The budget for 2023 projected an income of £642,259. The 2022 rise in charitable income to £664,322, stabilized to £640,943 in 2023, with the pattern of income being similar, the majority through the copyright licence for ‘MUST’ renewal, a successful conference, albeit a reduced profit (compared to pre-COVID times) of £21,539 (see below for details) and Industry/corporate sector membership, but this income was reduced by £19,450, with the financial pressures limiting the budgets of pharmaceutical industry. 

**Figure 2: Source of Income 2023** 


## **Expenditure** 

Overall charity expenditure has risen significantly post-COVID, from £173,340 in 2021, to £375,371 in 2022, and risen by a further £156,969 to £532,340 in 2023. The budget for 2023 projected expenditure of £660,840, which included a £80,000 research venture with a major University which fell-through. Conference incurred significantly more costs in 2023, being held in a larger venue in Edinburgh and increased audio-visual fees, but a higher quality of educational experience was delivered in doing so, one of the aims for 2023 and the coming years. The tender to change the secretariat and conference organizing company was awarded to Medivents in the previous year which added to the costs, over double at £76,810 for the secretariat. All bids at tender showed an increase in fees, but it was felt that value for money in awarding the contract to Medivents was justified. Database management for the Intestinal Failure Registry also rose but is off-set by the fee invoiced to NHSE. Travel costs have settled somewhat after the increase from the first full year post COVID, down from £10,415 to £5,681. Bookkeeping and accountancy costs have risen significantly but represent a much-enhanced level of service delivery: £2,458 in 2022 to £14,190 in 2023. 

## **Annual Conference, 2023** 

The Annual conference in 2021 was an on-line affair, which delivered excellent educational benefit but with a loss of income stream, to the extent there was an overall loss of £7,911 (income £16,928, costs £24,839, including cancellation charges of over £8,000). The 2022 conference was an in-person event and with a resurgent number of delegates the conference yielded greater profit than expected £85,956 (income £278,061, expenditure £192,105). The venue for 2023, Edinburgh was expected to have higher overheads as a larger dedicated Conference Centre vs a Conference Centre based in a 

8 



The British Association for Parenteral and Enteral Nutrition CIO for the period ended 31 December 2023 

hotel. An unexpected higher tariff occurred for higher quality audio-visual provision, but the educational experience was significantly enhanced by both of these changes, something that BAPEN Executive were happy to invest in. 

The 2023 Edinburgh BAPEN conference attracted the highest attendance in BAPEN’s history with over 700 delegates. Income was £6,805 greater than 2022, but expenditure was also higher by £71,222. A surplus was delivered of £21,539. With improved feedback regarding location, facilities and educational delivery, BAPEN look to continue this strategy of higher quality educational delivery. 

**Figure 3: Conferences Income, Expenditure and Profit 2014–2023** 


## **Reserves** 

Reserves continue to be distributed across five direct access and notice accounts with banks or building societies protected by the FSCS. These are categorized as low risk investments. In keeping with the reserves policy, the reserves will be spread among additional accounts. 

## **Reserves policy** 

The funds of the charity at the end of 2023 are £908,649, which is an increase of £117,446 compared to 2022 which were £791,203, compared to £499,474 at the end of 2021. There has been an increased expenditure of £156,969 in 2023 compared to 2022 as it was anticipated there would be a continued growth if the copyright/licensing continued to yield income. The charity sets a reserve policy that dictates that 12 months costs should be held in reserve. The reserves policy was reviewed in 2023 and the level set at £440,000 by the Trustees. This includes the need to protect the charity from failure of conference as was the case in 2020 due to the coronavirus pandemic. Financial planning for 2023 was made to ensure that these funds are invested into the charitable aims of BAPEN. We budgeted for a research project, but this fell through in 2023 due to a contract dispute between BAPEN and a University. This was a potential investment of almost £80,000. These funds are now being considered for redistribution. The website redesign and affordability of the new secretariat were also built into the 2023 plans. 

The Reserves Policy was set at £440,000 for 2024 at the Trustees meeting October 2023, and £460,000 for 2025. The Reserves Policy will require further review in 2025 for 2026-2029 given the rising costs and the possibility that the one major licensing/copyright contract is renewed annually. 

9 



The British Association for Parenteral and Enteral Nutrition CIO for the period ended 31 December 2023 

## **Plan for 2024/25** 

Investment of charitable funds will take place in line with priorities identified in BAPEN’s 5-year Strategy launch at the end of 2022. It is noted that the copyright licensing incomes, the largest generator of surplus/profit, are annual contracts and not necessarily a guaranteed income stream, but a renewal into 2024 provided continued confidence in BAPEN’s finances. The secretariat fees will continue to be greater than the years leading up to 2022, but the service is invaluable to the effective operation of the charity. Furthermore, whilst the 2022 conference was the most highly profitable to date, the venue left much to be desired, with poor feedback from both delegates and industry, related to the facilities. The 2023 conference was chosen to provide a more professional level of academic and educational learning opportunities and the forecast to make a much smaller profit margin was realized as per budget. The Database management for the IF Registry is making a small surplus, but it’s a resource to NHSE that is highly valuable for managing Intestinal Failure services in England and requires suitable recompense for the value it holds. With regards to public relations and media, the budgeted development of the website has gone well in 2023, and the focus in 2024 is the tender process for a public relation/media contract renewal. The costs for these services will be much greater, likely at least double the current contract, but will give BAPEN an improved platform to deliver its Strategic Aims and Objectives. 2024 -2026 will see staged investment into the work of the Core and Specialist Interest Groups (proposed £100,000 over 2-3-years), and Grants for Quality Improvement Projects and Research by BAPEN’s Members (again £100,000) over these 2-3-years. The Edgbaston Course is booked for Spring 2025, a course designed for the development of Nutrition Support Teams, funded by BAPEN, with around £35,000 budgeted. Thus, BAPEN is investing further in its charitable aims and objectives in accordance with the BAPEN Strategic Plan 2022-2027. 

Full copies of the accounts will be available on request from the BAPEN Office or directly on the Charity Commission website. 

## **Public Benefit** 

The Trustees believe that they have complied with their duty to have due regard to guidance on public benefit published by the Charity Commission in exercising their powers and duties. Public benefits requirements are met by the charity’s aims that every individual receives safe, timely & appropriate nutritional care in every care setting, every day and by offering free membership to the charity. 

## **STRUCTURE, GOVERNANCE AND MANAGEMENT** 

BAPEN is governed by its Constitution signed on 26[th] May 1993 which was revised on 29th November 2011 and again on 20th November 2018.  A new Constitution was approved by Trustees prior to registering the new CIO Charity on 3 December 2019.  In line with the revised Constitution, the Honorary Officers are also Trustees of the Association. 

The Governing Council of BAPEN, BAPEN Council, meets at least twice, usually four times a year and the Executive Committee which includes up to three Honorary Senior Officers as well as the Honorary President, Secretary and Treasurer meets at least every two months, usually eight or nine times a year. The Board of Trustees meets quarterly and ensures the organisation is meeting its charitable aims and objectives in line with the developed strategies.  Representatives of the founder organisations and associate organisations sit on the Council and Chairs of the standing committees of the association are also members of the Council.  An Independent Advisory Council of individuals, known as Faculty, who have made outstanding contributions to clinical nutrition and to the association, serve to offer guidance and support to the Association, hold a seat on the Trustee Board, and meet with the Executive Committee at least once a year. 

10 



The British Association for Parenteral and Enteral Nutrition CIO for the period ended 31 December 2023 

## **Appointment, recruitment and training of trustees** 

The Trustees of the Association are the Honorary Officers who are elected from the members of the Association at the Annual General Meeting held in November each year.  These officers are appointed for a 3-year term and may be re-elected for a maximum of three terms of office.  A process of succession planning is in place to ensure that the officers and therefore the Trustees retire over a staggered timeframe.  Newly appointed Trustees receive copies of the annual reports and accounts for the last three years and are required to read the Charity Commission’s guidance “The Essential Trustee: What You Need to Know”. 

## **Management of risks** 

The major risks to which the charity is exposed, as identified by the trustees, have been reviewed and systems and procedures have been established to manage those risks. 

11 



The British Association for Parenteral and Enteral Nutrition CIO for the period ended 31 December 2023 

## **REFERENCE AND ADMINISTRATIVE DETAILS** 

## **Charity registered name:** 

The British Association for Parenteral and Enteral Nutrition 

## **Charity registration number:** 1186719 (previously 1023927) 

## **Principal office address:** 

Medivents Ltd, Spirella Building, Bridge Road, Letchworth Garden City SG6 4ET 

## **Trustees:** 

The following were Trustees of BAPEN during the year: 

Dr Trevor Smith - President until 28[th] November 2023 

Dr Nick Thompson – President from 28[th] November 2023 

Dr Sheldon Cooper – Treasurer 

Dr Dan Rogers – Secretary 

Dr Barry Jones – Chair of Independent Advisory Council 

Mr Phil Lyons MBE – External Trustee 

Mrs Dianne M Jeffrey CBE DL - External Trustee Dr Roger Philips – External Trustee 

**Council** : The Council of BAPEN during the year were: 

Dr. T. Smith President (until 28/11/23) Dr. N. Thompson President from 28/11/23 Dr. S. Cooper Treasurer Dr. D. Rogers Secretary Dr. J. Fletcher Executive Officer Dr. E. Walters Executive Officer, Co-Chair (Enteral) BANS Ms. S-J. Hughes Executive Officer, Co-Chair (IF) BANS and Northern Ireland Co-Representative Ms. K. Hall Executive Officer Ms. W-L Relph Chair NG SIG Dr. E. Parsons Education Officer Ms P. Mistry BPNG Ms. N. Welsh NNNG Dr. A. Batra BSPGHAN Ms. L Cantwell PENG Dr. P. Allan BAPEN Medical until July 2023 Dr. I.Grecu BAPEN Medical July 2023-28/11/23 Dr E. Clarke BAPEN Medical from 28/11/23 Dr. B. Jones Chair of Independent Advisory Council Mr. P. Turner Programmes, Northern Ireland Co-Representative Mrs. C. Wheatley PINNT Dr. C. Childs Nutrition Society Dr. J. Nightingale BIFA Dr. R. Stratton MAG Amelia Jukes Wales Co-Representative Dr. F. Moroni Scotland Representative 

12 



The British Association for Parenteral and Enteral Nutrition CIO for the period ended 31 December 2023 

## **Independent Examiner:** 

Karen Hanlan ACA, ACIE Karen Hanlan Independent Examiner Ltd 1 Saracen Close Ettington CV37 7SZ 

## **Bankers:** 

National Westminster Bank plc Scottish Widows Bank Redwood Bank Approved by the Board and signed on its behalf by: 

## **Dr Sheldon Cooper Honorary Treasurer** 

**Date:** 15/10/2024 

13 



The British Association for Parenteral and Enteral Nutrition CIO for the period ended 31 December 2023 

## **Statement of trustees’ responsibilities** 

The trustees are required to prepare financial statements for each financial year which give a true and fair view of the state of the affairs of the charity and of the surplus or deficit incurred by the charity for that year.  In preparing those financial statements the trustees are required to: 

- select suitable accounting policies and then apply them consistently; 

- make judgments and estimates that are reasonable and prudent; 

- state whether applicable accounting standards have been followed, subject to any material departures disclosed and explained in the accounts; and 

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue to exist. 

The trustees have overall responsibility for ensuring that the charity has an appropriate system of controls, financial and otherwise. 

The trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy, at any time, the financial position of the charity and to enable them to ensure that the financial statements comply with the Charities Act 2011. 

They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities and to provide reasonable assurance that: 

- the charity is operating efficiently and effectively; 

- its assets are safeguarded against unauthorised use or disposition; 

- proper records are maintained and financial information used within the charity or for publication is reliable; 

- the charity complies with relevant laws and regulations. 

14 



## **BRITISH ASSOCIATION FOR PARENTERAL AND ENTERAL NUTRITION** 

## **INDEPENDENT EXAMINER'S REPORT** 

## **TO THE TRUSTEES OF BRITISH ASSOCIATION FOR PARENTERAL AND ENTERAL NUTRITION** 

I report to the trustees on my examination of the financial statements of British Association for Parenteral and Enteral Nutrition (the charity) for the year ended 31 December 2023. 

## **Responsibilities and basis of report** 

As the trustees of the charity, you are responsible for the preparation of the financial statements in accordance with the requirements of the Charities Act 2011 (the 2011 Act). 

I report in respect of my examination of the charity’s financial statements carried out under section 145 of the 2011 Act. In carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act. 

## **Independent examiner's statement** 

Since the charity’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of Institute of Chartered Accountants in England and Wales, which is one of the listed bodies. 

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect: 

- 1 accounting records were not kept in respect of the charity as required by section 130 of the 2011 Act; or 

- 2 the financial statements do not accord with those records; or 

- 3 the financial statements do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination. 

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached. 

**K Hanlan, ACA, ACIE 1 Saracen Close, Ettington, CV37 7SZ** 

Dated: 15 October 2024 

15 



**BRITISH ASSOCIATION FOR PARENTERAL AND ENTERAL NUTRITION** 

## **STATEMENT OF FINANCIAL ACTIVITIES** 

## _**FOR THE YEAR ENDED 31 DECEMBER 2023**_ 

|||**Unrestricted**|**Unrestricted**|
|---|---|---|---|
|||**funds**|**funds**|
|||**2023**|**2022**|
||**Notes**|**£**|**£**|
|**Income from:**||||
|Charitable activities|**2**|640,943|664,322|
|Investments|**3**|8,843|2,778|
|**Total income**||649,786|667,100|
|Expenditure on charitable activities|**4**|532,340|375,371|
|**Net income and movement in funds**||117,446|291,729|
|**Reconciliation of funds:**||||
|Fund balances at 1 January 2023||791,203|499,474|
|**Fund balances at 31 December 2023**||908,649|791,203|



The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities. 

16 



**BRITISH ASSOCIATION FOR PARENTERAL AND ENTERAL NUTRITION** 

## **BALANCE SHEET** 

## _**AS AT 31 DECEMBER 2023**_ 

|**Notes**<br>**Current assets**<br>Debtors<br>**9**<br>Cash at bank and in hand<br>**Creditors: amounts falling due within**<br>**10**<br>**one year**<br>Net current assets<br>**The funds of the charity**<br>Unrestricted funds|**2023**<br>**£**<br>199,650<br>880,333<br>1,079,983<br>171,334|<br>**£**<br>908,649<br>908,649<br>908,649|**2022**<br>**£**<br>135,890<br>807,310<br>943,200<br>151,997|<br>**£**<br>791,203|
|---|---|---|---|---|
|||||791,203|
|||||791,203|



The financial statements were approved by the trustees on 15/10/2024 

.............................. Dr Sheldon Cooper - Treasurer **Trustee** 

17 



**BRITISH ASSOCIATION FOR PARENTERAL AND ENTERAL NUTRITION** 

## **NOTES TO THE FINANCIAL STATEMENTS** _**FOR THE YEAR ENDED 31 DECEMBER 2023**_ 

## **1 Accounting policies** 

## **Charity information** 

British Association for Parenteral and Enteral Nutrition is a Charitable Incorporated Organisation. 

## **1.1 Accounting convention** 

The financial statements have been prepared in accordance with the Charities Act 2011, FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019). The charity is a Public Benefit Entity as defined by FRS 102. 

The charity has taken advantage of the provisions in the SORP for charities not to prepare a Statement of Cash Flows. 

The financial statements have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a true and fair view. This departure has involved following the Statement of Recommended Practice for charities applying FRS 102 rather than the version of the Statement of Recommended Practice which is referred to in the Regulations but which has since been withdrawn. 

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £. 

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below. 

## **1.2 Going concern** 

At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements. 

## **1.3 Charitable funds** 

Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives. 

Restricted funds are subject to specific conditions by donors or grantors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements, when relevant. 

## **1.4 Income** 

Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received. 

Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation. 

Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset. 

18 



**BRITISH ASSOCIATION FOR PARENTERAL AND ENTERAL NUTRITION** 

## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2023**_ 

## **1 Accounting policies** 

**(Continued)** 

## **1.5 Expenditure** 

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of the obligation can be measured reliably. 

Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. 

## **1.6 Cash and cash equivalents** 

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities. 

## **1.7 Financial instruments** 

The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments. 

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument. 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. 

## _**Basic financial assets**_ 

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised. 

## _**Basic financial liabilities**_ 

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised. 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method. 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method. 

## _**Derecognition of financial liabilities**_ 

Financial liabilities are derecognised when the charity’s contractual obligations expire or are discharged or cancelled. 

19 



**BRITISH ASSOCIATION FOR PARENTERAL AND ENTERAL NUTRITION** 

## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2023**_ 

|**2**|**Income from charitable activities**|||
|---|---|---|---|
|||**Unrestricted**|**Unrestricted**|
|||**funds**|**funds**|
|||**2023**|**2022**|
|||**£**|**£**|
||Corporate membership|74,400|93,850|
||Individual Affiliate / BAPEN Medical Membership|11,301|9,826|
||E-learning|-|1,880|
||Annual conference/virtual events|284,866|278,061|
||Projects|79,959|63,696|
||Copyright|170,680|190,833|
||Miscellaneous (Including ESPEN)|19,737|26,176|
|||640,943|664,322|
|**3**|**Income from investments**|||
|||**Unrestricted**|**Unrestricted**|
|||**funds**|**funds**|
|||**2023**|**2022**|
|||**£**|**£**|
||Interest receivable|8,843|2,778|
|**4**|**Expenditure on charitable activities**|||
|||**2023**|**2022**|
|||**£**|**£**|
||**Charitable events and activities**|||
||Promotion|64,988|46,414|
||Other charitable expenditure|7,219|7,821|
||Conference expenditure|263,327|192,105|
|||335,534|246,340|
||**Support and governance costs (see note 5)**|||
||Support|184,310|117,437|
||Governance|12,496|11,594|
|||532,340|375,371|
||**Analysis by fund**|||
||Unrestricted funds|532,340|375,371|



20 



**BRITISH ASSOCIATION FOR PARENTERAL AND ENTERAL NUTRITION** 

## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2023**_ 

## **5 Support costs** 

|Secretarial fees & expenses<br>Media Co-Ordinator<br>Office costs<br>Database Management<br>Travel<br>Meetings<br>ESPEN<br>Stationery<br>Bank charges<br>Bookkeeping & Accountancy<br>Insurance<br>Governance costs<br>**Governance costs comprise:**<br>Meetings<br>Legal & professional fees<br>Independent Examiners fee|**2023**<br>**£**<br>76,810<br>33,000<br>4,763<br>41,360<br>5,681<br>1,583<br>1,489<br>385<br>2,688<br>14,190<br>2,361<br>12,496<br>196,806<br>**2023**<br>**£**<br>9,718<br>1,628<br>1,150<br>12,496|**2022**<br>**£**<br>35,993<br>30,000<br>4,007<br>28,851<br>10,415<br>589<br>1,652<br>497<br>1,048<br>2,458<br>1,927<br>11,594<br>129,031<br>**2022**<br>**£**<br>6,694<br>3,400<br>1,500<br>11,594|
|---|---|---|



## **6 Trustees** 

None of the trustees (or any persons connected with them) received any remuneration or benefits from the charity during the year. 

No remuneration was paid to trustees. During the year travel expenses of £2,312 were claimed by 5 trustees for costs incurred in attending BAPEN meetings (2022 - £322 by 3 trustees). 

Trustee Indemnity Insurance has been paid for by the charity at a cost of £652. 

## **7 Employees** 

The Charity has no employees and uses the services of contractors to deliver its events and activities. 

## **8 Taxation** 

The charity is exempt from taxation on its activities because all its income is applied for charitable purposes. 

21 



**BRITISH ASSOCIATION FOR PARENTERAL AND ENTERAL NUTRITION** 

## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2023**_ 

|**9**<br>**Debtors**<br>**Amounts falling due within one year:**<br>Trade debtors<br>VAT recoverable<br>Prepayments|**2023**<br>**£**<br>154,416<br>9,796<br>35,438<br>199,650|**2022**<br>**£**<br>116,073<br>-<br>19,817<br>135,890|
|---|---|---|



## **10 Creditors: amounts falling due within one year** 

|**Notes**<br>VAT<br>Deferred income<br>**11**<br>Trade creditors<br>Accruals<br>**Deferred income**<br>Other deferred income<br>Deferred income is included in the financial statements as follows:<br>Deferred income is included within:<br>Current liabilities<br>Movements in the year:<br>Deferred income at 1 January 2023<br>Released from previous periods<br> <br>Resources deferred in the year<br>Deferred income at 31 December 2023|**2023**<br>**£**<br>-<br>7,980<br>155,174<br>8,180<br>171,334<br>**2023**<br>**£**<br>7,980<br>**2023**<br>**£**<br>7,980<br>107,500<br>(107,500)<br> <br>7,980<br>7,980|**2022**<br>**£**<br>39,135<br>107,500<br>240<br>5,122<br>151,997<br>**2022**<br>**£**<br>107,500<br>**2022**<br>**£**<br>107,500<br>169,133<br>(169,133)<br>107,500<br>107,500|
|---|---|---|



## **11 Deferred income** 

Deferred income relates to copyright and licence fees received in advance. 

22 



**BRITISH ASSOCIATION FOR PARENTERAL AND ENTERAL NUTRITION** 

## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2023**_ 

## **12 Unrestricted funds** 

The unrestricted funds of the charity comprise the unexpended balances of income, donations and grants which are not subject to specific conditions by donors and grantors as to how they may be used. These include designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes. 

|**At 1 January**<br>**2023**<br>**£**<br>General funds<br>791,203<br>**Previous year:**<br>**At 1 January**<br>**2022**<br>**£**<br>General funds<br>499,474|**Income**<br>**£**<br>**Expenditure**<br>**£**<br>**At 31**<br>**December**<br>**2023**<br>**£**<br>649,786<br>(532,340)<br>908,649<br>**Income**<br>**Expenditure**<br>**At 31**<br>**December**<br>**2022**<br>**£**<br>**£**<br>**£**<br>667,100<br>(375,371)<br>791,203|
|---|---|



## **13 Related party transactions** 

There were no disclosable related party transactions during the year (2022 - none). 

23